Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213) |
---|
02/14/2002 | WO2002011677A2 Treatment of hyperproliferative diseases with epidermal growth factor receptor antagonists |
02/14/2002 | WO2002011670A2 Solid forms of tin ethyl etiopurpurin and processes for producing such forms |
02/14/2002 | WO2001034088A3 Cardiac device for electrical and chemical regulation, and vasoactive intestinal peptide for treatment of cardiopulmonary disorders |
02/14/2002 | WO2001030802A3 Therapeutic treatments comprising administration of certain steroids for blood cell deficiencies |
02/14/2002 | WO2001021771A3 Compositions and methods for inhibiting g2 cell cycle arrest and sensitizing cells to dna damaging agents |
02/14/2002 | US20020019443 Therapeutic use of D-methionine to reduce the toxicity of noise |
02/14/2002 | US20020019356 Hyperbaric oxigenation (hbo) as the method for enhancement efficiency of anti-hiv substances in inhibition the human immunodeficiency virus (hiv) reproduction and reduction of the cytotoxic effect of those substances as well |
02/14/2002 | US20020019334 Nutritional intervention composition for enhancing and extending satiety |
02/14/2002 | US20020018752 Ablation disease by cutting, blocking blood supply to tissue |
02/14/2002 | CA2418083A1 Treatment of hyperproliferative diseases with epidermal growth factor receptor antagonists |
02/14/2002 | CA2418014A1 Immunotherapy for chronic myelocytic leukemia |
02/14/2002 | CA2417930A1 Pharmaceutical compositions containing lithium carbonate |
02/14/2002 | CA2417783A1 Solid forms of tin ethyl etiopurpurin and processes for producing such forms |
02/14/2002 | CA2417368A1 Suppressor gene |
02/14/2002 | CA2416531A1 Compositions for preventing urinary calculus |
02/13/2002 | EP1178811A1 Electrolyte gels for maintaining hydration and rehydration |
02/13/2002 | CN1335822A Method for reducing the bromide content in an aqueous bromide-containing solution using hydrogen peroxide |
02/13/2002 | CN1335164A Leukoderma treating medicine and its prepn |
02/13/2002 | CN1335154A Headache treating capsule |
02/13/2002 | CN1335149A Medicine for preventing and treating allergic bronchial asthma and its prepn |
02/13/2002 | CN1335148A Osteanaphysis capsule for treating femoral head necrosis |
02/13/2002 | CN1335145A External-use plaster for softening dry feces and dissipating mass |
02/13/2002 | CN1335144A Chinese medicine plaster for treating mastoproliferation and its prepn |
02/13/2002 | CN1335137A Soluble nutritious powder with elements, vitamins and amino acids and its prepn |
02/13/2002 | CN1335136A Oxygen-enriched NaCl injecta and its production process |
02/13/2002 | CN1079029C Medical capsule for treating bone rheumatism and its preparing process |
02/13/2002 | CN1079028C Method for preparing traditional Chinese medicine for lithangiuria and biliary tract calculus |
02/13/2002 | CN1079015C Calcium preparation and its used raw material, and producing process thereof |
02/12/2002 | US6346552 Breathing gas mixture containing perfluorocarbons |
02/12/2002 | US6346279 Antiseptics with phosphorous acid, anionic surfactants of alkylbenzenesulfonic acids and alkali or ammonium salts |
02/12/2002 | US6346258 Physiological combination of active substances to enhance the skin's defenses against noxious agents |
02/12/2002 | CA2073453C Methods of enhancing wound healing and tissue repair |
02/07/2002 | WO2002010242A1 Polyurethane film-forming dispersions in alcohol-water system |
02/07/2002 | WO2002009731A1 Use of co for treating inflammation of upper airways or bronchi |
02/07/2002 | WO2002009730A1 Oxygen-enriched agent and the use thereof for therapeutic purposes |
02/07/2002 | WO2002009729A2 Treatment of hyperproliferative skin disorders and diseases |
02/07/2002 | WO2002009727A1 Compositions and methods for improving cardiovascular function |
02/07/2002 | WO2002009699A2 Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract |
02/07/2002 | WO2002009693A1 Method and compositions for prevention and/or treatment of diabetes and glucose modulation |
02/07/2002 | WO2001035935B1 Inhibitors of endo-exonuclease activity such as pentamidine for the treatment of cancer |
02/07/2002 | US20020016368 Administering to a mammal a therapeutically effective amount of a compound of sulfonamide or alkanoy or amide derivative containing hetero or aromatic rings to treat osteoporosis, osteotomy, childhood idiopathic boen loss etc. |
02/07/2002 | US20020016313 Dietary calcium as a supplement to vitamin d compound treatment of multiple sclerosis |
02/07/2002 | US20020016288 Methods for production of the oxidized glutathione composite with cis-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells |
02/07/2002 | US20020016286 Simultaneous administration of human growth hormone in combination with DHEA, or their precursors, releasers, analogs, or metabolites; regenerating the human thymus to allow intrathymic transplantation |
02/07/2002 | US20020015742 For women; various concentrations |
02/07/2002 | US20020015741 Method and composition for the accelerated in vivo removal of ethanol |
02/06/2002 | EP1177793A1 Inhalable medicinal aerosol composition for pain treatment or prevention |
02/06/2002 | EP1177157A1 A vital matter and a producing method |
02/06/2002 | EP1176975A1 Pharmacokinetic and pharmacodynamic modeling of erythropoietin administration |
02/06/2002 | EP1176969A2 Substitution infusion fluid and citrate anticoagulation |
02/06/2002 | EP1176949A2 Lipid particles on the basis of mixtures of liquid and solid lipids and method for producing same |
02/06/2002 | EP1176948A1 Anti-nausea compositions and methods |
02/06/2002 | EP1176870A2 Tgf-alpha polypeptides, functional fragments and methods of use therefor |
02/06/2002 | EP1052987B1 Tablets to be crunched or sucked, comprising iron as active principle |
02/06/2002 | EP0931084B1 1,3-dicarboxylic germanium complex and its therapeutic use |
02/06/2002 | CN1334730A Vitronectin receptor antagonist |
02/06/2002 | CN1334119A Litholysizing bear gall powder |
02/06/2002 | CN1334112A Chinese medicine for treaitng coronary heart disease |
02/06/2002 | CN1334106A Chinese-herbal regulator for improving domestic animal |
02/06/2002 | CN1334087A Injection for treating piles and its preparing process |
02/06/2002 | CN1334086A Ointment for treating beriberi and ringworm of hand or foot |
02/05/2002 | US6344482 Omega-3 fatty acids in the treatment of bipolar disorder |
02/05/2002 | US6344444 Arginine-silicate-inositol complex and use thereof |
02/05/2002 | US6344210 Composition for freshening nostrils and sinus cavities |
02/05/2002 | US6344184 Synergistic combination of 0.005-0.05% w/v of an antibacterial agent selected from bisguanides (such as chlorhexidine or salts) and quaternary ammonium compounds and 0.05-0.5% w/v of zinc acetate. |
02/05/2002 | US6344181 Decreased endogenous nitric oxide activation |
02/05/2002 | CA2121123C Anti-seborrhoeic formulation |
02/03/2002 | CA2353364A1 Aerosol for the treatment or prevention of pain |
01/31/2002 | WO2002007717A1 Emulsion of perfluororganic compounds for medical purposes, method for producing said emulsion and methods for curing and preventing diseases with the aid of the emulsion |
01/31/2002 | WO2002007700A2 Compositions useful for regulating hair growth containing metal complexes of oxidized carbohydrates |
01/31/2002 | WO2002007520A2 Antimicrobial composition useful for the treatment of bovine mastitis |
01/31/2002 | US20020013484 Water solubility; prodrug containing polyether oligomer |
01/31/2002 | US20020013371 Therapy of acute myelogenous leukemia in a human by administering arsenic trioxide |
01/31/2002 | US20020013306 Terpyridine-platinum(ii) complexes |
01/31/2002 | US20020013298 Such as multiple sclerosis, by administering antimicrotubule agent: epothilones, discodermolide, deuterium oxide, hexylene glycol, tubercidin, LY-290181, alumimum fluoride, glycine ethyl ester, or ethylene glycol bis(succinimidylsuccinate) |
01/31/2002 | US20020013260 Ginsenoside chemotherapy |
01/31/2002 | US20020012957 Plasma-like solution |
01/31/2002 | US20020012931 High specificity marker detection |
01/31/2002 | US20020012715 Protecting cell from damage caused by free radicals by administering lipophilic antioxidant comprising vitamin E, beta carotene, extract of Lycopersicum esculentum, hydrophilic antioxidant comprising vitamin c, extract of vitis vinifera |
01/31/2002 | US20020012707 Multi-chamber container for storing bicarbonate solution comprising first chamber housing alkaline bicarbonate concentrate and second chamber housing acidic concentrate |
01/31/2002 | US20020012698 Magnetosomes, method for making and using |
01/31/2002 | DE10033762A1 Verfahren zum Entbromen einer wäßrigen Salzlösung unter Verwendung von Ozon A method for Entbromen an aqueous salt solution using ozone |
01/30/2002 | EP1175149A1 Disinfecting composition based on h2o2, acids and metal ions |
01/30/2002 | EP1091746B1 Use of iso-osmotic saline solutions for preparing cerumenolytic medicines |
01/30/2002 | EP0832198A4 Oxygen activatable formulations for disinfection or sterilization |
01/30/2002 | EP0707580B1 Magnesium omeprazole |
01/30/2002 | EP0675725B1 Medical foods for the nutritional support of infant/toddler metabolic diseases |
01/30/2002 | CN1333372A Process for preparing potide zinc easy absorbed in human body |
01/30/2002 | CN1333036A Hair-growing powder medicine and preparation process thereof |
01/30/2002 | CN1333033A Medical composition for treating leukoderma |
01/30/2002 | CN1333020A Biochemical material composition for preventing and treating disease caused by smooth muscle cell contraction in human organ |
01/30/2002 | CN1333019A Injection for treating traumatic injury |
01/30/2002 | CN1078477C Smoking-giving up tea and preparation |
01/30/2002 | CN1078475C Traditional Chinese medicine plaster for treating osteoproliferation |
01/30/2002 | CN1078471C Health medicine for tonifying kidney and its production process |
01/30/2002 | CN1078469C Material for adjusting function of biology |
01/29/2002 | USRE37534 Pharmaceutical compositions |
01/29/2002 | US6342528 Control of microbial populations in the gastrointestinal tract of animals |
01/29/2002 | US6342236 Cosmetic products compatible with cutaneous ecology |
01/29/2002 | US6342212 Adhesive latex formulation comprising at least one polymer constituent, at least one thickening agent, and at least one inorganic silver-based antimicrobial agent selected from ion exchange compounds, zeolites, and/or glasses |